Report of an independent peer review of an acrylonitrile risk assessment

Human and Experimental Toxicology

Volumn 24, Issue 10, 2005, Pages 487-527

  Haber, L T ^a   Patterson, Jacqueline ^a  

^a NONE   (United States)

Author keywords

Acrylonitrile; Carcinogenicity; Mode of action; PBPK modeling; Risk assessment

Indexed keywords

ACRYLONITRILE;

CANCER; CANCER MODEL; CANCER RISK; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; DATA BASE; DOSE RESPONSE; GENOTOXICITY; HUMAN; MOUTH CANCER; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PEER REVIEW; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TOXICOKINETICS;

ACRYLONITRILE; ANIMALS; CAUSALITY; CONFLICT OF INTEREST; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PEER REVIEW, RESEARCH; RISK ASSESSMENT; RISK FACTORS; TOXICOLOGY;

EID: 27644480319     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327105ht552oa     Document Type: Review

References (38)

1. Sakurai H, Onodera M, Utsunomiya T, Minakuchi H, Iwai H, Mutsumura H. Health effects of acrylonitrile in acrylic fibre factories. Br J Ind Med 1978; 35: 219-25.
2. Quast JF, Schuetz DJ, Balmer MF, Gushow TS, Park CN, McKenna MJ. A two-year toxicity and oncogenicity study with acrylonitrile following inhalation exposure of rats. Dow Chemical Co. Toxicology Research Laboratory, Midland Michigan for the Chemicals Manufacturing Association, Washington, DC (partially printed, complete report on disk), 1980.
3. Gagnaire F, Marignac B, Bonnet P. Relative neurotoxicological properties of five unsaturated aliphatic nitriles in rats. J Appl Toxicol 1998; 18: 25-31.
4. Sweeney LM, Gargas ML, Strother DE, Kedderis GL. Physiologically based pharmacokinetic model parameter estimation and sensitivity and variability analyses for acrylonitrile disposition in humans. Toxicol Sci 2003; 71: 27-40.
5. O'Berg MT. Epidemiologic study of workers exposed to acrylonitrile. J Occup Med 1980; 22: 245-52.
6. Benn T, Osborne K. Mortality of United Kingdom acrylonitrile workers-an extended and undated study. Scand J Work Environ Health 1998; 24: 17-24.
7. Swaen GMH, Bloemen LJN, Twisk J, Scheffers T, Slangen JM, Collins JJ et al. Mortality update of workers exposed to acrylonitrile in the Netherlands. Scand J Work Environ Health 1998; 24: 10-16.
8. Wood SM, Buffler PA, Burau K, Krivanek N. Mortality and morbidity of workers exposed to acrylonitrile in fibre production. Scand J Work Environ Health 1998; 24: 54-62.
9. Blair A, Stewart PA, Zaebst D, Pottern L, Zey J, Bloom T et al. Mortality of industrial workers exposed to acrylonitrile. Scand J Work Environ Health 1998; 24: 25-41.
10. Collins JJ, Acquavella JF. Review and meta-analysis of studies of acrylonitrile workers. Scand J Work Environ Health 1998; 24: 71-80.
11. International Agency for Research on Cancer (IARC). Evaluation of carcinogenic risks to humans. Acrylonitrile. Monograph, Volume 71, part I, pp. 43-108 and preamble, 1999.
12. Marsh GM, Youk AO, Collins JJ. Reevaluation of lung cancer risk in the acrylonitrile. Cohort study of the National Cancer Institute and the National Institute for Occupational Safety and Health. Scand J Work Environ Health 2001; 27: 5-13.
13. European Union (EU). Risk assessment of acrylonitrile. CAS. No. 107-13-1. EINECS No. 203-466-5. April, 2001. Draft.
14. Marsh GM. Mortality among workers from a plastics producing plant: a matched case-control study nested in a retrospective cohort study. J Occup Med 1983; 25: 219-30.
15. Friedman MA, Beliles RP. Three-generation reproduction study of rats receiving acrylonitrile in drinking water. Toxicol Letts 2002; 132: 249-61.
16. Recio L, Simpson D, Cocharane J, Liber H, Skopek TR. Mutational specificity of 2-cyanoethylene oxide in human lymphoblastoid cells. Environ Mol Mutagen 1989; 14: 162.
17. Quast JF. Two-year toxicity and oncogenicity study with acrylonitrile incorporated in the drinking water of rats. Toxicol Letts 2002; 132: 153-96.
18. Johannsen FR, Levinskas GJ. Comparative chronic toxicity and carcinogenicity of acrylonitrile by drinking water and oral intubation to Spartan(R) Sprague-Dawley rats. Toxicol Letts 2002; 132: 197-219.
19. Yates JM, Summer SCJ, Turner MJ, Recio L, Fennell TR. Characterization of an adduct and its degradation product produces by the reaction of cyanoethylene oxide with deoxythymidene and DNA. Carcinogenesis 1993; 14: 1363-69.
20. Yates JM, Fennell TR, Turner MJ, Recio L, Sumner SC. Characterization of phosphodiester adducts produced by the reaction of cyanoethylene oxide with nucleotides. Carcinogenesis 1994; 15: 277-83.
21. Solomon JJ, Singh US, Segal A. In vitro reactions of 2-cyanoethylene oxide with calf thymus DNA. Chem-Biol Interact 1993; 88: 115-35.
22. Schulz MR, Herts-Picciotto I, Todd L, Ball L. Reconciling animal and human data in a cancer risk assessment of acrylonitrile. Scand J Work Environ Health 2001; 27: 14-20.
23. Ward CE, Starr TB. Comparison of cancer risks projected from animal bioassays to epidemiologic studies of acrylonitrile workers. Regul Toxicol Pharmacol 1993; 18: 214-32.
24. Bio/dynamics. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered in the drinking water to Spartan rats. Bio/dynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, under project no. 77-1745 for Monsanto Company, St Louis, MO, 1980.
25. Bio/dynamics. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered in the drinking water to Fischer 344 rats. Bio/dynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, under project no. 77-1746 for Monsanto Company, St Louis, MO, 1980.
26. Bio/dynamics. A twenty-four month oral toxicity/carcinogenicity study of acrylonitrile administered by intubation to Spartan rats. Bio/dynamics Inc., Division of Biology and Safety Evaluation, East Millstone, NJ, under project no. 77-1745 for Monsanto Company, St Louis, MO, 1980.
27. Health Canada. Priority substances list assessment report. Acrylonitrile, 2000.
28. Werner JB, Carter JT. Mortality of United Kingdom acrylonitrile polymerisation workers. Br J Ind Med 1981; 38: 247-53.
29. Thiess AM, Frentzel-Beyme R, Link R, Wild H. Mortalitatsstudie bei hemiefacharbeitern verschiedener Produktionsbetriebe mit exposition auch gegenuber acrylonitril. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergon 1980; 30: 259-67.
30. Starr TB, Gause CK, Stone RA, Youk AO, Marsh GM, Collins JJ. A risk assessment for occupational acrylonitrile exposure using epidemiology data. Risk Anal 2003; 24: 587-601.
31. United States Environmental Protection Agency (US EPA). Benchmark dose software (BMDS) version 1.3.2. 2003. Available at http://cfpub.epa.gov/ncea/cfm/ recordisplay.cfm?deid = 20167
32. Kedderis GL, Teo SK, Batra R, Held SD, Gargas ML. Refinement and verification of the physiologically based dosimetry description for acrylonitrile in rats. Toxicol Appl Pharmacol 1996; 140: 422-35.
33. Kirman CR, Hays SM, Kedderis GL, Gargas ML, Strother DE. Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: an analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the rat. Risk Anal 2000; 20: 135-51.
34. Maltoni C, Ciliberti A, Dimaio V. Carcinogenicity bioassays on rats of acrylonitrile administered by inhalation and ingestion. Med Lavoro 1977; 68: 401-11.
35. Osterman-Golkar S, MacNeela JP, Turner MJ, Walker VE, Swenberg JA, Sumner SCJ et al. Monitoring exposure to acrylonitrile using adducts to N-terminal valine in hemoglobin. Carcinogenesis 1994; 15: 2701-707.
36. Jiang J, Xu Y, Klaunig JE. Induction of oxidative stress in rat brain by acrylonitrile (ACN). Toxicol Sci 1998; 46: 333-41.
37. Grunske F. Ventox and ventox-poisoning. Dtsch Med Wochenschr 1949; 74: 1081.
38. United States Environmental Protection Agency (US EPA). Health assessment document for acrylonitrile. EPA-600/8-82-007F. October, 1983.